Strong Q4 Earnings Ahead of the Bell: TWX, GSK, ALK

GSK T YUM ALK

Wednesday, February 8, 2017

A slew of new Q4 earnings reports hit the tape this morning, covering a wide range of industries from pharma to airlines to media. Included among these are some buy-rated companies, according to our trusted Zacks Rank, including GlaxoSmithKline (GSK - Free Report) , Alaska Airlines (ALK - Free Report) and Time Warner .

In Glaxo’s case, the London-based Big Pharma staple outperformed expectations on top and bottom lines on strength in vaccines, HIV treatments and a weaker British pound. The Zacks Rank #2 (Buy) company with a Style Score of A established full-year guidance of 5-7%, despite some concerns about generic drugs taking some market share.

Zacks Rank #2 Time Warner posted earnings up 18% from a year ago and 6 cents per share above the Zacks consensus estimate, to $1.25 per share. Quarterly revenues of $7.89 billion also topped estimates and rose 11% year over year, largely based on strong content offerings from its HBO and Warner Brothers segments. The company had accepted a buyout offer from AT&T (T - Free Report) , but this deal may be subject to scrutiny both from regulatory bodies and President Trump himself.

For more information on Time Warner’s earnings, click here.

Alaska Air also put up a beat on both top and bottom lines, with $1.56 per share and $1.52 billion in sales beating the $1.41 and $1.43 billion expected. The regional airline — which completed its purchase of Virgin America nearly two months ago — routinely beats earnings estimates (it has not missed in at least the last 5 quarters), and increased its dividend yield 9%. This stock is also a Zacks Rank #2.

For more information on Alaska Air’s earnings, click here.

After the bell today, we will see earnings results from Yum! Brands (YUM - Free Report) and Whole Foods Market . Both companies currently carry a Zacks Rank #3 (Hold).

Mark Vickery

Senior Editor

Click here to follow this author>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>